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Gap junctionResearch conducted over the past two decades has provided convincing evidence that cell death, andmore specif-
ically apoptosis, can exceed single cell boundaries and can be strongly inﬂuenced by intercellular communication
networks.We recently reported that gap junctions (i.e. channels directly connecting the cytoplasm of neighboring
cells) composed of connexin43 or connexin26 provide a direct pathway to promote and expand cell death, and
that inositol 1,4,5-trisphosphate (IP3) diffusion via these channels is crucial to provoke apoptosis in adjacent
healthy cells. However, IP3 itself is not sufﬁcient to induce cell death and additional factors appear to be necessary
to create conditions inwhich IP3will exert proapoptotic effects. Although IP3-evokedCa
2+ signaling is known tobe
required for normal cell survival, it is also actively involved in apoptosis induction and progression. As such, it is
evident that an accurate ﬁne-tuning of this signalingmechanism is crucial for normal cell physiology, while amal-
function can lead to cell death. Here, we review the role of IP3 as an intracellular and intercellular cell death mes-
senger, focusing on the endoplasmic reticulum-mitochondrial synapse, followed by a discussion of plausible
elements that can convert IP3 fromaphysiologicalmolecule to a killer substance. Finally,we highlight several path-
ological conditions in which anomalous intercellular IP3/Ca2+ signaling might play a role. This article is part of a
Special Issue entitled:12th European Symposium on Calcium.
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Several intracellular key events in various cell death modes are
triggered/regulated by Ca2+ signals [1–3]. However, research from the
past 20 years has demonstrated that cell death is not a ‘privilege’ of one
single cell, but that the message can be actively transferred to healthy
cells in close contact with the dying cell, a process termed bystander
death [4]. Cell-to-cell communication is established by vast arrays of
plasma membrane channels called gap junctions (GJs) which directly
connect neighboring cells [5]. GJs allow the passage of small molecular
weight (MW) molecules (b1–1.5 kDa) including glucose, glutamate,
glutathione, cyclic adenosine monophosphate (cAMP), adenosine
5′-triphosphate (ATP), inositol 1,4,5-trisphosphate (IP3) and ions
(e.g. Ca2+, K+, Na+, Cl−) [5,6]. They are composed of 12 transmem-
brane connexin (Cx) proteins of which more than 20 isoforms have
been identiﬁed in mammals [7]. Their nomenclature is based on their
MW, which ranges from 25 to 62 kDa. Cxs also form hemichannels
(HCs), positioned as pores between the intra- and extracellular
environment [8]. Of note, pannexins are another family of channel-
forming proteins that also constitute HCs, but these are less likely to
assemble into GJs [9–12]. Cxs are present in most organs and display a
tissue and cellular speciﬁcity with Cx43 being the most abundant Cx
in mammals [7,13].
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well as non-channel functions as demonstrated by Cx knockout (KO)
studies in mice and the association of several human diseases with mu-
tations of speciﬁc Cx genes [13,14]. However, the very same communica-
tion pathways can have deleterious consequences as well, including an
active contribution to the intercellular spreading of cell death signals
fromdying to healthy neighboring cells. The role of GJs in cell death com-
munication -primarily apoptosis- has already been ﬁrmly established
and an increasing number of reports demonstrate that HCs can kick in
by forming toxic pores in the plasmamembrane or providing a paracrine
cell death communication pathway [4,15,16]. One major caveat in this
research area is related to identifying the signal(s) which convey the
cell deathmessage. Importantly, we recently demonstrated that the pas-
sage of the Ca2+messenger IP3 throughGJs is crucial for intercellular cell
death communication using an in vitro apoptosis model. This work pro-
vided evidence that the physiological messenger IP3 becomes a toxic
intercellularmessengerwhen the cells that are generating IP3, are under-
going apoptosis [17]. This review furnishes an overview of what is
known about the role of IP3 in cell death on the intracellular and
intercellular level, focusing on the intrinsic mitochondria-related path-
way of apoptosis. Finally, the importance of targeting this intercellular
pathway will be underscored by discussing some pathologies where
intercellular IP3 spreading could contribute to exaggerated cell death.
2. IP3, a major determinant of intra- and intercellular
Ca2+ signaling
The discovery of IP3 as a secondmessenger about 30 years ago can be
regarded as one of the major breakthroughs in understanding how cells
can chemically relay stimuli from the plasma membrane to intracellular
Ca2+ increases [18]. Numerous extracellular stimuli act on plasmamem-
brane receptors and subsequently trigger phospholipase C (PLC) activity.
There are 13 different PLC isoforms which are divided in six different
classes based on their structure: PLCβ, PLCγ, PLCδ, PLCε, PLCζ and PLCη.
They can be activated via different mechanisms including the
stimulation of G-protein-coupled receptors (GPCRs), receptor and
non-receptor tyrosine kinases, the activation of the small G-protein
Ras, or an increase in cytoplasmic Ca2+ concentration ([Ca2+]i) [19].
PLC catalyzes the cleavage of phosphoinositol-4,5-bisphosphate into
diacylglycerol and IP3. The latter diffuses in the cytoplasm and binds its
receptor which is mainly located on the endoplasmic reticulum (ER),
the largest and most controllable intracellular Ca2+ source [2]. The sub-
sequent cytoplasmic Ca2+ rise can take many different forms which are
highly organized in both time and space, with oscillations appearing as
repetitive and localized Ca2+ spikes, and localized Ca2+ increases
being ampliﬁed into spreading waves respectively. This spatiotemporal
organization forms the basis for a versatile signaling system used by
virtually all cell types—excitable as well as non-excitable cells [20,21].
The Ca2+ signaling system needs to be endowed with sufﬁcient re-
liability and speciﬁcity to control various physiological processes as di-
verse as fertilization, cell proliferation, differentiation, neurotransmitter
release, secretion, gene expression, immune responses, muscle contrac-
tion, endothelial permeability, apoptosis and many others [22,23]. Re-
petitive oscillating Ca2+ spikes encode information in their amplitude,
spike duration and frequency [24]. Single Ca2+ transients, on the
other hand, tend to last longer and the resulting signal usually spreads
out as a cytoplasmic Ca2+ wave. These waves are not always restricted
to the cytosol of one cell but can propagate toward other cells as
intercellular Ca2+waves [20,21]. Ca2+waves can be communicated be-
tween cells by GJs as well as paracrine signaling. Since Ca2+ passage via
GJs is known to be limited due to the presence of cytoplasmic Ca2+
binding proteins, IP3 is considered to be the primary coordinating mes-
senger [25–27]. IP3 has a much higher effective diffusion constant com-
pared to Ca2+ (283 μm2/s versus 13–65 μm2/s respectively), and a 100
times larger GJ permeability over Ca2+ [27,28]. ATP is considered to be
the primary paracrine messenger, released in the extracellular space,and acting on GPCRs or triggering Ca2+ entry via plasma membrane
channels in neighboring cells [29–33]. Multiple pathways can be in-
volved in the release of ATP including exocytosis, diffusion through
either Cx or pannexin HCs, or P2X receptor channels [30,34–41].
Intercellular wave propagation is most of the times sustained by both
the gap junctional and paracrine pathway [32,42,43], and supported
by regenerative steps. These steps include the regeneration of IP3 by
the Ca2+-triggered activation of PLCδ [28], and the Ca2+-dependency
of several ATP release mechanisms [34,37,44]. Both mechanisms even-
tually result in more extensive wave propagation [21]. Intercellular
Ca2+ wave propagation has been observed in in vitro monolayer cul-
tures of diverse cell types (e.g. glial cells, endothelia, hepatocytes),
where they generally spread with a velocity of 10–40 μm/s in response
to a variety of stimuli [35,43,45,46], as well as in ex vivo and in vivo
conditions [31,47–50]. It appears to be a fundamental mechanism to
synchronize the function of a large group of cells.
Both GJs and HCs also inﬂuence the occurrence of Ca2+ oscillations.
GJs are known to modulate the spike frequency, the number of cells
displaying Ca2+ oscillations and the synchronization of Ca2+ oscilla-
tions [45,51–53]. HCs seem to be involved in the generation of Ca2+
oscillations through the activation of different regenerative signaling
loops starting with the Ca2+-induced opening of HCs followed by ATP
or nicotinamide adenine dinucleotide release, or the uptake of Ca2+
itself via open HCs [54–56].
3. Intracellular Ca2+ signaling: a combined effort between IP3
receptors, the ER and mitochondria
The spatiotemporal organization of Ca2+ signals largely depends on
(i) the characteristics and (ii) the spatial distribution of the Ca2+ release
channels involved. The IP3 receptor (IP3R) is a tetramer with each
subunit consisting of a cytoplasmic N-terminal (NT) domain which
is composed of a suppressor domain and an IP3-binding core, a
C-terminal (CT) channel domain (six transmembrane domain), and an
intervening regulatory and coupling domain [57]. The latter mediates
the transfer of the ligand binding signal from the IP3-binding domain
to the channel domain. This domain also functions to keep the
inactivated IP3R channel closed and contains many target sites for reg-
ulators of IP3R activity [57,58]. IP3Rs are widely expressed in different
types of organs and tissues. The gating of IP3Rs (i.e. closing and opening
of the channel) is inﬂuenced by different factors including cytoplasmic
IP3, Ca2+ and ATP concentrations, ER luminal Ca2+ concentration,
redox and phosphorylation status, and protein interactions [57,58]. Of
note, the afﬁnity for IP3 binding and the sensitivity of the IP3R to the
modulatory signals depend on the isoform ofwhich the receptor is con-
stituted (IP3R1, IP3R2 or IP3R3) [57–59]. The best known regulatory fac-
tor is [Ca2+]i which has a biphasic action on the receptor: Ca2+
activates the receptor at low concentrations (100–300 nM), but be-
comes inhibitory at higher concentrations (above 300 nM) [60–65].
The spatial organization of IP3Rs is related to the arrangement of
IP3Rs as clusters on the ER, as well as their close contact with other
Ca2+-sequestering organelles such as mitochondria [66,67]. The role
of mitochondria in cellular Ca2+ signaling has been underestimated
for a long time, but it becomes increasingly recognized that mitochon-
dria actively participate in shaping the Ca2+ signaling pattern [68,69].
Mitochondria extrude protons to create an electrochemical gradient
that enables ATP synthesis. The same gradient is used to drive mito-
chondrial Ca2+ uptake, with the voltage-dependent anion channel
(VDAC) in the outer mitochondrial membrane (OMM) and the recently
identiﬁed mitochondrial Ca2+ uniporter (MCU) in the inner mitochon-
drial membrane (IMM) as major regulators; in addition to other,
less well-characterized transport systems [2,3,70–72]. Mitochondria
accumulate Ca2+ more effectively when they are close to sites of high
Ca2+ concentration [73,74]. Different reports have demonstrated that
IP3Rs can be concentrated, together with other proteins involved in
cellular Ca2+ homeostasis like the sarco-endoplasmic reticulum
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the near vicinity of mitochondria [67,75]. Here, local microdomains,
termed hot spotswith Ca2+ concentrations exceeding 9 μM, are created
upon IP3-induced Ca2+ release (IICR) in the vicinity of mitochondria
[76]. These hotspots create high local Ca2+ concentrations that over-
come the low afﬁnity of the MCU. The maximal activation of mitochon-
drial Ca2+ uptake is reported to require >16 μM [Ca2+]i [77]. The
uptake system necessitates an optimal distance between the site of
IICR and the mitochondria [76]. The physical association between the
ER and mitochondria is known as the mitochondria-associated ER
membrane (MAM) [75,78,79]. The interaction between the ER and the
mitochondria depends on structural contacts consisting of different
types of proteins including some mitochondria-shaping proteins
(mitofusin-1 and -2) and chaperone proteins such as the glucose-
regulated protein (grp) 75. The latter physically links VDAC1 to the
IP3R, thereby enhancing mitochondrial Ca2+ accumulation [80]. The
primary role of Ca2+ uptake into the mitochondrial matrix is the
stimulation of the mitochondrial ATP production by activating
Ca2+-sensitive matrix dehydrogenases of the Krebs cycle, which are
key sites of NADH production for the respiratory chain [81–83]. Once
the [Ca2+]i has then returned to its resting level, a mitochondrial
Na+/Ca2+ exchanger or H+/Ca2+ antiporter pumps the Ca2+ back
into the cytoplasm, from which it is either recycled to the ER or re-
moved from the cell [69,84–86].
4. IP3: from survival factor to ruthless killer
4.1. The ER-mitochondria connection in apoptosis
Although controlled Ca2+ increments are indispensable for normal
cell physiology, it is generally accepted that a sustained elevation leads
to cell death [1,2]. Moreover, the duration and extent of the Ca2+ re-
sponse may determine whether cells survive, activate autophagy, or
die by apoptosis or necrosis [1,3,87–89].
The function of Ca2+ in cell death proves to be a complex subject.
There is no one-way route fromCa2+ to cell death but the path rather in-
volves the interplay between many systems, activating different parts of
the cell death program. Changes in Ca2+ distributionwithin intracellular
Ca2+ compartments, primarily the ER, signiﬁcantly contribute to the
modulation of cell death. Firstly, disturbances in the ER Ca2+ pool can af-
fect chaperones and hamper protein folding, leading to ER stress. Subse-
quently, an unfolded protein response is initiated in order to remove the
incorrectly folded and accumulated proteins in the ER [90]. ER stress can
induce autophagy, a catabolic cellular program that facilitates the remov-
al of damaged proteins. Under severe stress, however, these signals be-
come detrimental and may initiate apoptosis or necrosis [91,92]. An
impaired interaction between IP3R1 and the ER luminal chaperone
grp78 can promote apoptosis during ER stress [93]. Secondly, ER Ca2+
release can be sensed by the mitochondria, resulting in mitochondrial
Ca2+ overload and apoptosis [1,3,94]. ER Ca2+ release itself has been
shown to be sufﬁcient to induce apoptosis without the necessity of an
overall increase in [Ca2+]i or store-operated Ca2+ entry [95,96], andma-
nipulating ER luminal Ca2+ concentration can alter the sensitivity of cells
to apoptosis [97]. Moreover, a very close apposition between the ER and
mitochondria makes the latter more prone to Ca2+ overload and the
cells more susceptible to apoptosis [98]. Recently, the presence of
IP3R3, not IP3R1, and VDAC1 in the MAM have been implicated in the
proapoptotic Ca2+ transfer between the ER and the mitochondria
[99,100]. The magnitude and pattern of the Ca2+ signal received by the
mitochondria appears to be a very important factor in determining cell
fate. Small oscillatory Ca2+ signals from ER to mitochondria can have a
pro-survival action by stimulating the mitochondrial energy production
or by inducing transcription of speciﬁc genes [81,82,101]. A high and
persistent mitochondrial Ca2+ increase, however, causes a sudden
increment in the permeability of the IMM due to the opening of the
permeability transition pore (PTP). This results in mitochondrialdepolarization, inhibition of the respiratory chain, production of reactive
oxygen species (ROS),matrix swelling due to osmotic forces, remodeling
of the IMM, and ﬁnally permeabilization of the OMM. The latter leads to
the release of various proapoptotic factors into the cytosol such as
Cytochrome C (CytC), SMAC/Diablo or apoptosis-inducing factor
[1,102,103]. The subsequent activation of caspases (a speciﬁc class of cys-
teine proteases) is required for the rapid manifestation of the typical
morphological features of apoptosis. Cessation of the Ca2+ signal can
close the PTP again, allowing recovery of mitochondrial metabolism
and production of ATP, while CytC release from themitochondria results
in caspase activation [104]. Necrotic cell death has also been associated
with PTP opening and OMM permeabilization. It is generally accepted
that the intracellular ATP concentration is the decisive factor in deter-
mining the mode of cell death. The progression toward apoptosis re-
quires energy and a depletion of the intracellular ATP pool results in
necrosis [103,105]. Of note, a rapid ﬂuctuation between the open and
closed state of the PTP has been observed in healthy intact cells as well,
providing a more physiological role to its opening [106]. Little is known
about the molecular identity of the PTP. The long-standing idea is that
it consists of a large protein complex that comprises the VDAC (in the
OMM), the adenine nucleotide translocator (ANT; carrier in the IMM),
mitochondrial cyclophilin D and several other proteins. As of today, how-
ever, it is not clear whether the VDAC and ANT, or even the OMM, are
critical channel-forming components of the PTP [107–110]. Next to PTP
opening, other factors can affect the OMM integrity, including the
proapoptotic B-cell lymphoma-2 (Bcl-2) family members Bax and Bak.
Their exact mechanistic contribution remains unclear, but their oligo-
merization appears to be a requirement. The oligomers could form chan-
nels or destabilize the mitochondrial membrane which is subsequently
permeabilized by lipid pores [111–113]. Bax and Bak, as well as other
pro-apoptotic Bcl-2 proteins, have also been shown to interact with
VDAC, regulate its properties or assemble into higher-ordered complexes
[70,114–117]. Several lines of evidence indeed suggest that VDAC can be
regulated by different Bcl-2 family members; anti-apoptotic proteins
inhibit VDAC functioning while pro-apoptotic proteins promote it
[118–121]. In addition, VDAC oligomers appear to be critically involved
in the release of pro-apoptotic proteins including CytC from the inner
membrane space [118,122–125].
IP3 and its receptor have attracted a lot of attention in the regulation
of apoptotic pathways since: (i) reducing IP3R expression has been
shown to reduce the susceptibility of cells to apoptosis [126–129], (ii)
the amount of Ca2+ taken up by the mitochondria seems to be critically
dependent on the pulse of IICR [77], (iii) IICR can trigger PTP opening in
cells exposed to subtoxic proapoptotic stimuli [104] and can also activate
a variety of Ca2+-sensitive proteins that engage other apoptotic mecha-
nisms (e.g. activation of the phosphatase calcineurin that subsequently
dephosphorylates the proapoptotic protein Bad, resulting in CytC release
from mitochondria [130]) and (iv) more than 50 different proteins can
interact with and regulate the IP3R, including a number of pro- and
antiapoptotic proteins [3,57,131,132]. Although IP3R KO studies
suggested a redundant participation of each isoform in apoptosis, recent
reports demonstrated that the presence of IP3R3 is crucial to mediate
proapoptotic ER-to-mitochondria Ca2+ transfer [99,100,126,133]. Intra-
cellular IP3 generation is the ‘physiological way’ of activating IP3Rs. Li-
gands such as Tumor Necrosis Factor-α (TNF-α) and Fas ligand acting
via the extrinsic death receptor-mediated pathway, or the activation of
the B-cell receptor in immature B cells have been shown to promote
IP3 generation, IICR and subsequent apoptotic cell death [126,134,135].
In addition to the direct role of the IP3R in the initiation of apoptosis,
there are several feedbackmechanismswhich equip IP3Rswith ampliﬁer
functions. These include cleavage of the receptor by caspase 3, and the
direct binding and regulation of the IP3R by several key apoptotic mole-
cules including CytC and the antiapoptotic proteins Bcl-2, Bcl-Xl and
Bax-Inhibitor-1 (BI-1) [3,131,132,136]. The site of CytC binding on the
IP3R1 has been localized within the CT tail of the IP3R (amino acids
2621-2636) [137]. The functional effect of CytC on the channel consists
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probability, thereby promoting proapoptotic Ca2+ release. It is proposed
that a vicious circle is at play here - a partial release of CytC activates
Ca2+ release from IP3Rs, feeding back to mitochondria to promote
additional CytC release. A cell permeant peptide derived from the CytC
binding site blocked IP3R-CytC interactions and abrogated intrinsic
mitochondria-related and extrinsic death receptor-mediated apoptosis
[138]. Binding of CytC to IP3R1 and ryanodine receptor (RyR) type 2, an-
other Ca2+ release channel present in the ER membrane, has also been
observed in vivo in the hippocampus of gerbils subjected to transient
brain ischemia/reperfusion [139].
A secondmodel of IP3R activation during apoptosis involves the pro-
teolysis of the IP3R1 by caspase 3 at amino acid 1892, i.e. in the distal
part of the regulatory domain. This cleavage results in the generation
of a 215 kDa NT fragment that includes the IP3 binding region, and a
95 kDa CT fragment containing the six transmembrane domains that
form the ion channel. It leaves the channel domain, rendered insensitive
to IP3, intact in the ER membrane and is probably responsible for pro-
viding a continuous Ca2+ leak from the ER [128,140]. An important re-
mark is that two recent papers claim that IP3R1 is a relatively late and
poor substrate of caspase 3, and that the caspase 3-cleaved IP3R1 iso-
form does not contribute to Ca2+ release after apoptosis induction
[141,142]. Of note, calpains, a family of Ca2+-dependent cysteine prote-
ases activated during apoptosis, have also been reported to cleave the
IP3R1. The cleavage disrupts neuronal Ca2+ homeostasis and enhances
the sensitivity of neuronal cells to excitotoxic stimuli [143].
Finally, it is increasingly recognized that a number of pro- and
antiapoptotic Bcl-2 family members are present in the ER membrane,
and modulate ER Ca2+ signaling [3,132,144,145]. Furthermore, there
is substantial evidence that several anti-apoptotic proteins such as
Bcl-2, Bcl-Xl, Mcl-1 and BI-1 bind the IP3R and modulate its activity.
The resulting effects on IICR (activation versus inhibition) and the cor-
responding antiapoptotic mechanism are still a matter of debate. First
of all, Bcl-Xl, Bcl-2 and Mcl-1 have been shown to bind the CT of all
three IP3R isoforms, thereby increasing the sensitivity of the IP3R to
subsaturating IP3 concentrations and causing the appearance of Ca2+
oscillations. The latter confer resistance to apoptosis [146–149]. A sec-
ond mechanism involves a Bcl-2-mediated ER Ca2+ leak, thereby de-
creasing ER Ca2+ levels and the subsequent mitochondrial Ca2+
uptake. Here, Bcl-2 was demonstrated to interact with the IP3R and
change its phosphorylation status [150]. Thirdly, Bcl-2 is also reported
to inhibit IICR and subsequent Ca2+ uptake by mitochondria
[151,152]. Anti-apoptotic Bcl-2 members share conservation in all four
Bcl-2-homology (BH1-4) domains. BH1, BH2 andBH3 formahydropho-
bic groove responsible for binding the BH3 domain of the proapoptotic
proteins Bax and Bak, thereby prohibiting OMM permeabilization
[153,154]. It was recently demonstrated that in contrast to the BH4
domain of Bcl-Xl (BH4-Bcl-Xl), the BH4 domain of Bcl-2 (BH4-Bcl-2)
binds the regulatory and coupling domain of all three IP3R isoforms
and inhibits IICR [155,156]. This difference in IP3R regulation between
BH4-Bcl-2 and BH4-Bcl-Xl also controls their antiapoptotic action
in response to CytC- and staurosporine (a protein kinase C
inhibitor)-induced apoptosis, i.e. BH4-Bcl-2 was more potent in
inhibiting apoptosis than BH4-Bcl-Xl [155]. Moreover, a synthetic pep-
tide, corresponding to the Bcl-2 binding site on the IP3R1 (amino acids
1389-1408), was able to speciﬁcally disrupt the interaction between
BH4-Bcl-2 and the IP3R, and to counteract the effects on IICR and
apoptosis [155–157]. Very recently, proﬁling of the Bcl-2 and
Bcl-Xl-binding site on the IP3R1 revealed that Bcl-2 targets the central,
modulatory domain and the CT channel domain with similar efﬁcien-
cies, while Bcl-Xl mainly targets the CT channel domain [149]. These
molecular differences between Bcl-2 and Bcl-Xl in binding IP3Rs may
underlie their differential action on IP3R-mediated Ca2+ signaling,
with Bcl-2 acting as an inhibitor of proapoptotic Ca2+ transients [158]
and Bcl-Xl acting as an enhancer of pro-survival Ca2+ oscillations
[146,147]. Thus, although it is clear that both Bcl-2 and Bcl-Xl inﬂuenceIICR, they appear to have distinct effects of which the precise mecha-
nism of action awaits further clariﬁcation. Recent data indicates that
the antiapoptotic protein BI-1 also interacts with IP3R1 and IP3R3.
Mouse embryonic ﬁbroblasts (MEFs) overexpressing BI-1 display a sen-
sitized IICR and an increased cell survival in response to thapsigargin
(SERCA pump inhibitor) -induced ER stress [136]. Thus far, there are
no reports of a direct interaction between the proapoptotic members
Bax and Bak, and the IP3R.
4.2. IP3, the missing link between the intrinsic apoptotic pathway and
intercellular cell death spread?
About seven years ago, we started our investigations on the
intercellular cell death signaling making use of an in vitro model to
study cell death spread through Cx channels (Fig. 1) [17,159]. This
consisted of loading a small strip of an adherent C6 glioma cell culture,
stably transfected with Cx43 or Cx26, with the apoptotic agent CytC
(MW12.4 kDa) bymeans of in situ electroporation. The latter can be ap-
plied to introduce high-MW and plasmamembrane-impermeable mol-
ecules into a well-deﬁned area of cells [160]. CytC was chosen as the
apoptotic agent due to some unique characteristics: (i) the molecule
is not cell-permeable and could therefore be locally applied by means
of in situ electroporation, (ii) the molecule is not GJ-permeable (MW
12.4 kDa), so it can not readily diffuse to neighboring cells, and (iii)
CytC is a downstream and common component in many apoptotic
pathways. Apoptosis rapidly developed in the CytC-loaded zone (‘trig-
ger zone’; morphological changes appeared approximately 15–30 min
after electroporation), but a more attenuating formwas also detectable
6 h later in surrounding cells (‘communication zone’). Using wild-type
non-transfected cells, Cx channel blockers and siRNA, we demonstrated
that GJs contribute to apoptosis spread to cells adjacent to the trigger
zone while HCs also promoted cell death further away from this area.
Most importantly, intracellular Ca2+ changes were involved in the in-
duction of apoptosis mediated by both Cx channels as concluded from
experiments with the intracellular Ca2+ chelator BAPTA-AM [159].
There is a substantial amount of evidence available suggesting that
Ca2+ ﬂuxes are part of the intercellular killing mechanism in many dif-
ferent models, and that inhibiting Ca2+ increases protects cells against
cell death spread [159,161–165]. In turn, an elevation of [Ca2+]i may
provide a positive feedback mechanism for PLC activation to generate
the Ca2+-mobilizing messenger IP3 [28]. IP3 is indeed proposed to be
the prototype candidate to communicate these Ca2+ changes, most no-
tably since IP3 can permeate through GJs and IICR can triggermitochon-
drial permeability transition and CytC release. The latter can in its turn
interact with IP3Rs to potentiate ER Ca2+ release, and activate caspases
which proteolytically cleave the receptor. Both of these mechanisms
provide an enhanced ER Ca2+ leakage pathway and exacerbate mito-
chondrial Ca2+-driven CytC release in a vicious circle (see Section 4.1)
(Fig. 2). Furthermore, IICR can also evoke Bax translocation to mito-
chondrial membranes and cells microinjected with recombinant Bax
display Ca2+ wave propagation to neighboring cells [166,167].
In a next step of investigations, we set out to verify whether IP3,
transferred through GJs, is responsible for the Ca2+-dependent cell
death spread to neighboring cells. To function as a cell deathmessenger,
IP3 has to fulﬁll three different criteria: (i) it has to be generated in
the intrinsic mitochondrial pathway downstream of CytC release
[159,162,168–170], (ii) it has to be transferred through GJs [25,26]
and (iii) it has to possess the potential to trigger cell death. Using in
situ electroporation, we were able to separate the role of IP3 in the trig-
ger zone and in the cells receiving the cell death message via GJs, by in-
terfering with IP3 signaling in these two different areas (Fig. 1). More
speciﬁcally, we applied a human type I IP3 5-phosphatase (MW
43 kDa) and an IP3R-inhibitory peptide (BH4-Bcl-2; MW 3.6 kDa) in
the cells via a double in situ electroporation protocol (Fig. 1). Finally,
we transduced a cell line with a mutant Cx forming GJs with an im-
paired permeability to IP3 [171]. From the obtained results it was
Fig. 1. Interfering with IP3 signaling reduces apoptosis spread via GJs in an in vitro glioma model. A. Procedure to perform in situ electroporation loading of the apoptosis-inducing
agent CytC. An electrode consisting of two platina-iridium (Pt-Ir) wires is placed above an adherent monolayer cell culture. A small volume of a low-conductivity electroporation
buffer solution containing CytC and a dextran ﬂuorescent reporter marker (to identify the loaded zone afterwards) is applied between the two electrode wires. Subsequently, an
alternating (50 kHz) voltage is applied to the electrode in a pulsed manner and not containing any ‘direct current’ (DC) component, as described in detail in [159,160]. B. In this
manner, it is possible to load a small area (300 μm wide and 7 mm in length, depending on the electrode size) with CytC, thereby triggering cell death in this zone (‘trigger
zone’). The ﬂuorescent reporter in the image shown is 10 kDa Dextran Texas Red, giving red ﬂuorescent staining of the trigger zone. The ﬁrst morphological signs of apoptosis ap-
pear within 15 min after CytC loading [159]. The scale bar measures 200 μm. C. Analysis of apoptosis in the ‘communication zone’ (located next to the trigger zone) was done using
a caspase in situmarker (green staining) combined with nuclear DAPI staining (blue). Cell death appearance in this area is clearly visible 6 h after CytC loading. Previous work with
this model has demonstrated that bystander cell death is strongly dependent on the presence of GJs composed of Cx43 or Cx26 [17,159]. The scale bar measures 50 μm. D. To in-
vestigate the role of IP3 in bystander cell death communication, we interfered with IP3 signaling by stimulating its degradation with a human type I IP3 5-phosphatase, by blocking
the IP3R with the inhibitory peptide BH4-Bcl-2 and by transducing wild-type communication deﬁcient C6 cells with a mutant Cx which forms IP3 -impermeable GJs. These three
approaches resulted in reduced bystander cell death, providing evidence that the generation of IP3 in the trigger zone, its diffusion through GJs and its presence in the communi-
cation zone is crucial to propagate cell death beyond the trigger zone. However, loading of the trigger zone with IP3 (up to 200 μM, CytC not included) did not evoke apoptosis [17].
E. Example image illustrating dual electroporation loading. The ﬂuorescent reporter in the trigger zone was green ﬂuorescent while the one in the communication zone was red
ﬂuorescent. Such procedure was used to load the trigger zone with CytC and the communication zone with IP3 5-phosphatase or an IP3R-inhibitory peptide [17]. The scale bar measures
200 μm.
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is transferred through GJs and is crucial for the induction of apoptosis in
the communication zone. Although IP3 appeared to be the key messen-
ger in communicating cell death between cells, high intracellular con-
centrations of IP3 by themselves (up to 200 μM; applied via in situ
electroporation loading) were not sufﬁcient to induce apoptosis—not
in the trigger zone and not in the communication zone. Initially, it
seemed counterintuitive that a small molecule like IP3, which is a phys-
iological messenger in the very ﬁrst place, would function as a cell killer
molecule. However, additional experiments did indicate that Ca2+ sig-
nals produced by IP3 potentiate apoptosis spread when superimposed
with a low concentration of CytC (i.e. concentration too low to result
in bystander death by itself).
There are several indications that IICR can sensitize the cells to
apoptotic stimuli. For example, the application of the IP3-generating
agonist histamine to MEFs enhanced apoptosis when it was applied
concurrently with the proapoptotic stimuli arachidonate, ceramide
and H2O2 [172]. Moreover, similar conditions have been described
in the past whereby activating the IP3 signaling pathway had to be
combined with a (sub)toxic stimulus to induce cell death. Szalai et
al. [104] demonstrated that IP3Rs release very small amounts ofCa2+ to evoke transient PTP opening, mitochondrial depolarization,
and apoptosis in cells primed with a subtoxic apoptotic trigger
(ceramide and staurosporine). In the absence of the apoptotic trigger,
PTP opening was relatively insensitive to IICR. A more recent study
established evidence that activation of caspase 3 and the resulting
truncation of the IP3R1 are required to generate signiﬁcant levels of
cytosolic Ca2+ and the rapid execution of apoptosis [128]. Important-
ly, an additional apoptotic trigger substance (staurosporine) was cru-
cial to induce an increased Ca2+ response over a prolonged time
period in a stable cell line expressing the truncated IP3R, and to trig-
ger apoptosis. Hence, in these studies as well as in ours, an additional
trigger or condition, next to IICR, is required to execute the cell death
program.
4.3. A double hit mechanism that sensitizes cells to apoptotic IP3
signaling?
The decision to stay alive or diemay ﬁrst of all rely on themessenger
that is transmitted, but may further depend on the condition of the cell
receiving themessage. If the concerned cell is concomitantly exposed to
additional stress stimuli, then IP3 may switch from a physiological to a
Fig. 2. A double-hit mechanism that sensitizes cells to apoptosis evoked by IICR. IP3 (and possibly its metabolite IP4) play a crucial role in apoptosis by activating the IP3R and mediating the
transfer of Ca2+ from the ER to mitochondria (red arrows) [3]. This can result in mitochondrial Ca2+ overload, disturbed energy production, increased ROS generation and OMM perme-
abilization (MMP) via PTP opening, Bax/Bak pore formation, homo-oligomers of VDAC, or hetero-oligomers composed of VDAC and pro-apoptotic proteins. Subsequently, CytC release
frommitochondria activates caspases [1]. Both of these apoptotic proteins have been shown to act at IP3Rs and potentiate Ca2+ release from the stores [128,137,140], exacerbatingmitochon-
drial Ca2+-driven CytC release in a vicious circle (depicted in red).We and others have demonstrated that additional factors (molecules/conditions) are required to sensitize cells to apoptosis
evoked by IICR according to a double-hit scenario [17,104,128,172]. Here, we speciﬁcally illustrate only thosemolecules that can be transferred through GJs and have been linked to bystander
effects (pink arrows). Variousmolecules that are generated during apoptosis can pass viaGJs (depicted in green), e.g. substances such as ROS, Ca2+, cAMP, cGMP, ormolecules producedduring
the apoptotic process via proteolytic cleavage (denoted as damage-associated molecules (DAMs)) [4,165,175]. All of these molecules could sensitize cells to apoptosis by acting at the
ER-mitochondria synapse (blue arrows). At the level of the ER, they may potentiate IICR by directly or indirectly (e.g. via kinase/phosphatase activation) affecting IP3R gating or IP3R–protein
interaction [57,58]. The proapoptotic proteins Bax and Bak were reported to be crucial for cell death propagation [225]. ER-located Bax and Bak have been demonstrated to induce
ER-to-mitochondria Ca2+mobilization or alter ER Ca2+ levels [172,226]. Moreover, reduced activity of ER Ca2+ uptake mechanisms (SERCA pump) can also result in an enhanced/prolonged
ER tomitochondria Ca2+ transfer [214]. All of the factors regulating IICR could also exert direct or indirect effects at the level of themitochondria and affect their functioning e.g. by inﬂuencing
their Ca2+ uptake mechanisms, respiratory activity and stimulating ROS production [102,228]. In addition, molecules/conditions that alter the ER-mitochondria conduit (e.g. the
ER-mitochondria anchorage sites at the mitochondria-associated ERmembrane (MAM) or the ER-mitochondria strategic positioning) could potentiate IICR and mitochondrial Ca2+ overload
[173,288]. However, detailed knowledge on the processes that regulate the linkage between these two organelles is currently lacking. The decision of a cell to stay alivemay also depend on the
concomitant exposure of cells to paracrine signaling molecules (depicted in orange) released from dying cells (black arrows) by various mechanisms including the direct passage via an im-
paired plasma membrane barrier. Additionally, HCs which are half of a GJ channel, may function as paracrine release pathways for factors such as IP3, ROS, ATP and glutamate (Glu)
[238–242,244,245]. ATP and Glu may trigger [Ca2+]i changes by activating GPCRs (purinergic or glutamatergic metabotropic receptors) or ionotropic receptor channels (P2X receptors
[P2XRs] or ionotropic Glu receptors [iGluRs]). HC opening may also accommodate the entry of molecules like Ca2+, IP3 or ROS, next to other possible uptake mechanisms such as a direct
entry via theplasmamembrane. Finally, it is likely that a groupofmessengers, insteadof one singlemolecule, canorchestrate their effects to sensitize cells to IICR and consequently to apoptosis.
Note that the schematic diagram only depicts those molecules that might be involved in the communication of a cell death message between cells.
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question of how exactly IP3 contributes to cell death in bystander cells
can thus be reduced to the search for molecules or conditions responsi-
ble for sensitizing cells to IICR and acting at either the ER (e.g. altering
the sensitivity of the IP3R, the Ca2+permeability of the IP3R, the number
of IP3Rs on the ER membrane or the ER steady-state Ca2+ levels) or
the mitochondria (e.g. affecting mitochondrial Ca2+ accumulation,
oxidative phosphorylation and ROS production) (Fig. 2). As such, the
list of additional elements leading to cell death is expected to be exten-
sive. Moreover, factors altering the ER-mitochondria conduit (e.g. the
anchorage sites between ER andmitochondria, or the strategic position-
ing of the mitochondria to sites of IICR) can potentiate mitochondrial
Ca2+ overload. Ferrari and colleagues [173] demonstrated that the acti-
vation of the intrinsic apoptotic pathway, not the extrinsic pathway,
causes functional and structural alterations at both the ER and mito-
chondria. This occurs before the appearance of biochemical and
morphological signs of apoptosis, and could affect the efﬁciency ofER-to-mitochondria Ca2+ transfer. However, detailed knowledge on
the components that pull their weight in these processes remains
scarce. Below, we will discuss plausible signals that can contribute to
the double-hit mechanism, speciﬁcally focusing on modulators that
have been linked to bystander effects (Fig. 2).
4.3.1. A subtoxic trigger provided by GJ-permeable damage-associated
molecules
A ﬁrst plausible mechanism is the simultaneous gap junctional trans-
fer of proteins that are involved in the apoptotic pathway and that im-
pose a direct subtoxic effect on bystander cells. The molecular size of
most of these components including CytC, caspases or Bcl-2 familymem-
bers is largely above the 1–1.5 kDa cut-off and precludes their passage
through the channels. It is however likely that during the apoptotic pro-
cess damage-associated molecules (DAMs) are generated, e.g. via the
cleavage of substrates by caspases, which are small enough to be trans-
ferred through GJs (Fig. 2). The number of deﬁned caspase substrates is
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proteolytic fragments generated by caspase cleavage are stable for at
least 4 h (in cells that died within 6 h after apoptotic stimulation).
Even more interesting, they noticed that a number of persistent peptide
fragments corresponded to distinct, stably folded protein domains, lead-
ing them to speculate that caspase-mediated proteolysis yields a class of
protein fragments with new activities. This mechanism seems to be of
particular importance in generating peptides in apoptotic cells which
are then transferred through GJs for cross-presentation by antigen
presenting cells [175]. It has been shown that peptides up to 1850 Da
(or about 10 amino acids) could diffuse through GJs, depending on the
3D conformation of the peptide [176]. Using the online webserver
cascleave for the computational identiﬁcation of caspase substrate cleav-
age sites from primary substrate sequences (http://sunﬂower.kuicr.
kyoto-u.ac.jp/~sjn/Cascleave/help.html), we identiﬁed a potential cleav-
age site about half-way of the CytC sequence (residue 51 (SYTD*ANKN)).
This implies that cleavage products of approximately 6 kDa are generat-
ed, which are too large to pass GJs. However, evidence has accumulated
that non-caspases, including cathepsins, calpains, granzymes, and the
proteasome complex, also play a role in mediating and promoting cell
death [177]. Hence, we can hypothesize that GJ-permeable fragments
of CytC, or other modulatory proteins, are created which still can inﬂu-
ence IP3R channel activity and activate the vicious Ca2+-CytC circle lead-
ing to apoptosis. Of note, the exact IP3R-binding site on the CytC
molecule is, to our knowledge, still unidentiﬁed.
4.3.2. IP3Rs as Ca
2+ leak channels in apoptosis
The regulation of the IP3R channel activity is quite complex and has
been the subject of intense investigation. Several GJ-permeable mole-
cules can inﬂuence the expression or gating of IP3Rs, e.g. Ca2+, H+,
ATP, oxidative agents, substances that inﬂuence the phosphorylation
status by activating kinases/phosphatases, or factors that modulate
IP3R–protein interactions (Fig. 2) [57,58]. Changes in any (or a combina-
tion) of those GJ-permeable regulatory factors can occur under stress
conditions andmay result in the behavior of IP3Rs as Ca2+ leak channels
in neighboring cells [178]. IP3Rs are bimodally regulated by [Ca2+]i
[60–65]. The inhibition of IP3Rs by Ca2+ is thought to be a crucialmech-
anism for terminating channel activity and thus preventingpathological
Ca2+ rises. Most intriguingly, IP3Rs are not always inhibited by high
[Ca2+]i and the Ca2+-dependent regulation appears to be isoform-
dependent [179–182]. IP3R1 is reported to be the only isoform that is
consistently inhibited by high [Ca2+]i, both in intact cells and in
reconstituted lipid vesicles. Discrepant reports appeared about the ef-
fect of [Ca2+]i on IP3R3, showing either a bimodal regulation or only a
stimulatory phase with no high Ca2+-dependent negative feedback
[183,184]. IP3R3 also appears to be the isoform that preferentially trans-
mits apoptotic Ca2+ signals tomitochondria [99,100,133]. Furthermore,
it is reported that in the presence of high IP3 levels, the IP3R seems to be-
come insensitive to the inhibitory action of Ca2+. Here, a rapid inhibi-
tion of the IP3R by Ca2+ only occurs if the IP3R is not bound by IP3
[185]. This change in Ca2+ sensitivity can form the basis for magnifying
ER-to-mitochondria Ca2+ transfer. In addition, Ca2+ dynamics also
shape IP3 metabolism. Ca2+ can inﬂuence both synthesis and degrada-
tion of IP3 [186,187]. All PLC isoforms require Ca2+ for their activity
[19]. The only isoform that is known to be inactive at basal [Ca2+]i is
PLCδ. PLCδ is activated by micromolar Ca2+ concentrations, suggesting
that it functions as an ER Ca2+ release ampliﬁer that becomes activated
downstream of other PLC isoforms [188,189]. At the level of IP3 degra-
dation, IP3 can either be dephosphorylated by the IP3 5-phosphatase
to yield inositol 1,4-bisphosphate or phosphorylated by the IP3
3-kinase into inositol 1,3,4,5-tetrakisphosphate (IP4). This IP3 3-kinase
is Ca2+-sensitive as binding of Ca2+/calmodulin enhances its activity,
thereby modulating IP3 levels and increasing the concentration of IP4.
The latter has a 30 times larger half-life than IP3, may act to sustain
Ca2+ signals initiated by IP3 and thus contribute to its pathological
effects [190]. Hence, a large increase in Ca2+, as observed in responseto different pathological stimuli, may enhance IP3 and IP4 production,
resulting in a potentiation of ER Ca2+ release and a lethal outcome.
IP3Rs can sense the cellular redox state and an aberrant activation
of IP3Rs by oxidative agents (e.g. H2O2 and thimerosal) has been
reported in many studies [191–198]. IP3R1, not IP3R2 and IP3R3, was
found to be controlled by the binding of ERp44, a thioredoxin family
protein implicated in oxidative protein folding. The interaction is de-
pendent on pH, ER luminal Ca2+ concentration, and the presence of
free cysteine residues in the third luminal loop of IP3R1 [199]. Oxida-
tion of the IP3R results in an open channel and ER Ca2+ depletion.
Overexpression of ERp44 was found to inhibit apoptosis, which dem-
onstrates the importance of oxidative agents in regulating apoptosis
via the IP3R [199]. It has been known for a long time that oxidative
stress is tightly intertwined with Ca2+ homeostasis and signaling. Mi-
tochondrial Ca2+ overload can lead to apoptosis through the genera-
tion of ROS [200]. The dissipation of the mitochondrial membrane
potential is often accompanied by an increased generation of ROS,
which quickly saturate the antioxidant systems, ultimately resulting
in the functional impairment of mitochondria and PTP opening. Addi-
tionally, ROS may diffuse via GJs to neighboring cells, as has been pro-
posed in the context of endothelium-dependent contractions [201].
Oxidative stress also stimulates gap junctional coupling and promotes
the presence of HCs in the PM. Both effects were associated with in-
creased recycling of Cx proteins to the membrane [202,203]. These
observations suggest that ROS might regulate and exacerbate their
own spread via IICR and GJs. Several reports have indeed demonstrat-
ed that ROS play a crucial role in bystander effects, particularly those
induced by irradiation, to which GJs and paracrine signaling signiﬁ-
cantly contribute [204–208]. However, the premise that ROS are pro-
totypic bystander messengers in their own right is in our opinion
disputable because of the short life time and limited diffusion dis-
tance of these substances. This leads us to conclude that the generat-
ed ROS might be too unstable to reach the bystander cells. On the
other hand, long-lived radicals induced by ionizing radiation have
been suggested to be communicated to bystander cells [209]. In our
recording conditions, a gradual enhancement in ROS production
was observed with time after CytC electroporation. ROS generation
was blocked by the antioxidant N-acetyl L-cystein but this treatment
did not inﬂuence bystander cell death, which suggests that ROS
does not take part in the cell death spreading process [17].
IP3R channel activity is also potentiated by the GJ-permeable mole-
cule ATP (MW 517 Da), albeit in an isoform-dependent manner. The
general mechanism consists of an increase of the channel sensitivity
to Ca2+ activation [210,211]. Most intriguingly, cytosolic ATP levels
were found to be augmented in various cell types in response to differ-
ent apoptotic stimuli (staurosporine, TNF-α, etoposide) [212]. We
equally detected an elevated intracellular ATP concentration 1 h after
CytC loading (unpublished observation). On the other hand, enhanced
ATP levels can also inﬂuence ER Ca2+ uptake mechanisms. Verbert et
al. [140] demonstrated that caspase 3-mediated truncation of the
IP3R1 creates a modest leak, but does not lead to a complete emptying
of the ER Ca2+ store. It was hypothesized that a limited elevation of
mitochondrial Ca2+ activates ATP production which enhances ER
Ca2+-pump activity, compensating in this way for the initial Ca2+
leak from the ER. So, under normal conditions, IICR is largely compen-
sated by an enhanced ER-uptake. In contrast, situations in which the
cellular metabolism and consequently the Ca2+-uptake mechanism is
compromised, may lead to the execution of the apoptotic cascade. Sim-
ilar to the IP3R channel, the activity of SERCA is sensitive to oxidative
stress. ROS can induce SERCA pump inhibition and degradation, causing
an elevation of [Ca2+]i and cell death [213,214].
Various pro- and antiapoptotic proteins can interact with the IP3R
including some kinases/phosphatases such as protein kinase A (PKA),
protein kinase G (PKG), Akt kinase and the phosphatase calcineurin.
IP3Rs have been recognized as substrates for these different enzymes
[131,215–217]. The activity of many of these protein kinases and
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molecules. PKA and PKG activity for example is controlled by the mole-
cules cAMP (MW 329 Da) and cyclic guanosine monophosphate
(cGMP) (MW 345 Da), both of which can pass through GJs and modu-
late the apoptotic process [218–220]. PKA and PKG can have both stim-
ulatory and inhibitory actions on IICR [221–224]. In addition, the
regulation of IP3Rs by kinases/phosphatases is isoform-dependent. For
example, it was recently shown that Akt kinase functions speciﬁcally
on IP3R3, but not on IP3R1. Akt inhibits the ER-to-mitochondria Ca2+
transfer via IP3R3 and protects against Ca2+-mediated apoptosis in-
duced by arachidonic acid [100].
By inducing apoptosis via transfection of GFP-Bax in double-KO
Bax and Bak MEFs, Peixoto et al. [225] have demonstrated that the
presence of Bax and/or Bak are necessary to mediate apoptosis spread
to bystander cells. IICR induces Bax translocation to the mitochondria,
and Bax promotes Ca2+ wave propagation to neighboring cells
[166,167]. Bax and Bak also localize at the ER where Bax has been
demonstrated to promote Ca2+ mobilization from the ER to the
mitochondrion during apoptosis [226]. On the other hand, reduced
ER Ca2+ levels and a decreased mitochondrial Ca2+ uptake were
observed in the Bax and Bak double KO MEFs, thereby decreasing
the sensitivity to apoptotic Ca2+ signaling. The underlying mecha-
nism comprises a basal IP3R1-mediated Ca2+ leak due to interac-
tion with Bcl-2 and a PKA-dependent hyperphosphorylation and
hypersensitization of the receptor. Hence, the hypothesis was
raised that the ratio of pro- versus antiapoptotic Bcl-2 family
members controls ER Ca2+ levels. Interestingly, overexpression of
SERCA in the double KO MEF cells restored their ER Ca2+ levels
and their sensitivity to apoptosis induction [150,172]. Thus, the
pro-apoptotic signaling molecules Bax and Bak can affect bystander
death at different levels of ER Ca2+ handling and by modulating IICR
in a direct or indirect manner.
Finally, IP3Rs form macromolecular signaling complexes at the ER
and can exert functions independent of their channel activity. Based
on experiments with an IP3R1 construct containing a mutation that in-
activates the pore of the Ca2+ channel (D2550A), Khan et al. [227] con-
cluded that the intrinsic ion-channel function of the IP3R is dispensable
for staurosporine-induced apoptosis. The CT tail on the other hand
appeared to be essential, possibly reﬂecting key protein-protein inter-
actions with this domain.
4.3.3. Mitochondria, integrators of survival and death signals
At the level of the mitochondria, Ca2+ overload is known to be a de-
cisive factor for mitochondrial membrane permeabilization, an irrevers-
ible step toward cell death [228]. As a consequence, potentiating
mitochondrial Ca2+ uptake is expected to induce/accelerate cell death.
To investigate this, we superimposed intracellular IP3 loading with a
subtoxic concentration of the ionophore A23187, to evoke Ca2+ entry
from the extracellular space, or thapsigargin, which provokes ER Ca2+
leakage. Application of these additional stimuli did not induce the level
of bystander death observed after CytC loading [17]. It has to be noted
that the source of Ca2+ and the speed with which Ca2+ accumulates in
the mitochondria is reported to play an important role in determining
whether Ca2+ overload and subsequent mitochondrial membrane per-
meabilization occurs. For example, thapsigargin evokes a slow mito-
chondrial Ca2+ load while IP3 can elicit rapid ER-to-mitochondria Ca2+
transfer [104]. On the other hand, the switch from life to death may
also involve the mitochondrial detection of Ca2+ signals concomitant
with other proapoptotic stimuli that affect the functioning of these or-
ganelles. As mentioned above, IICR can sensitize the cells to different
(sub)toxic stimuli. All of these stimuli (staurosporine, arachidonate and
ceramide) have their main targets at the level of the mitochondria
[104]. Mitochondria have indeed been proposed to function as ‘coinci-
dence detectors’. Published reports have demonstrated that apoptosis
requires a synergism between high mitochondrial Ca2+ and other
signals including ROS production or the presence of lipid secondmessengers such as ceramide [95,172,229]. Mitochondria integrate di-
verse anti- and proapoptotic signals emanating from different compart-
ments, and the fate of the cell is shifted toward cell death if the lethal
ones predominate. Similar to the regulation of IP3R activity, there are
several local players at the mitochondrial level that link the various
signals and eventually determine whether mitochondrial membrane
permeabilization occurs: regulation of the PTP-forming proteins ormito-
chondrial Ca2+ uptake mechanisms (e.g. Ca2+/calmodulin-dependent
protein kinase II promotes PTP opening andmyocardial death by increas-
ing the MCU current [230]), the pro- and antiapoptotic members of the
Bcl-2 family, intermediate metabolites, redox processes, sphingolipids,
ion gradients, transcription factors, as well as kinases and phosphatases
[102,228,231]. Hence, the factors discussed above in the context of the
IP3R could also exert effects at the level of the mitochondria and affect
their functioning.
An important remark is that Cxs, in particular Cx43, but also Cx32
and Cx26, have been localized in mitochondrial membranes, mainly in
the IMM [232–235]. Recent evidence suggests that Cxs function here
as a channel across the mitochondrial membrane, likely with a
HC-like structure [236]. Cellular stress and ischemic preconditioning
have been shown to increase its mitochondrial localization [232–235].
Moreover, a survival role for mitochondrial Cx43 was attributed based
on the observations that conventional Cx channel inhibitors can
induce/facilitate PTP opening and CytC release from isolated mitochon-
dria [233,234]. In linewith this, overexpression of Cx43 inmitochondria
counteracts CytC release and apoptosis [237]. Although the detailed
molecular mechanism is not clariﬁed yet, Cx43 is suggested to keep
the PTP in a closed state.
4.3.4. An interplay between gap junctional and paracrine signaling
during apoptosis
A ﬁnal hypothesis consists of the release of paracrine substances
from dying cells which then act on plasma membrane receptors on
neighboring cells and work in concert with IP3 to induce apoptosis.
HCs are a possible pathway for messenger release. They are reported
to open in response to intracellular Ca2+ increases and various patho-
logical stimuli, and to contribute to cell death via the release of para-
crine molecules [4,15,16,165]. Most attention has been paid to ATP
and glutamate as substances contributing to neuronal cell death associ-
ated with ischemia and Alzheimer disease [238–242]. HCs are bidirec-
tional pathways that may also facilitate the uptake of components
including Ca2+, ROS and even IP3 [243–245]. Zhao and colleagues
[245] suggested that the HC-mediated release of IP3 from isolated co-
chlea and the subsequent re-entry via these channels in neighboring
cells is important for long distance Ca2+ signaling and, as such, for nor-
mal hearing. The lifetime of IP3 in the cytoplasm is known to be limited,
but the function as well as the metabolism (including buffering pro-
teins) of extracellular IP3 is, to our knowledge, largely unexplored. In
another study, the membrane-impermeable sodium salt of IP3 is
reported to be cardioprotective as perfusion of this molecule in intact
rabbit hearts reduced the infarct size after coronary occlusion [246].
Transport via HCs might be involved since the GJ- and HC inhibitor
heptanol, and the Cx mimetic peptide Gap27 abolished the effect of
IP3. IP3Rs have also been reported to be present in the plasma mem-
brane, but the IP3-binding site is located intracellularly. A few plasma
membrane IP3Rs appear to be sufﬁcient to trigger Ca2+ entry in the
DT40 B-cell line in response to B-cell receptor stimulation [247].
5. Pathological implications of IP3-based Ca2+ waves
During the past decade, intercellular Ca2+waves have been demon-
strated in several ex vivo and in vivo conditions including brain slices, in-
tact organs such as perfused rat liver or in vivo in the brain [31,47–50].
Although several physiological functions have been proposed for
intercellular Ca2+ waves, they seem to be frequently associated with
pathological signaling, primarily because the intensity/duration of the
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range [21]. Moreover, a wide diversity of pathologies have been linked
with abnormal IP3/Ca2+ signaling and unwarranted cell death, includ-
ing heart disease (e.g. heart failure) and brain diseases (e.g. ischemia,
Alzheimer's disease) [248]. Both organs are endowed with GJs com-
posed of different Cxs that contribute to their normal functioning. In
the heart, GJs are required for the synchronized contraction of the
cardiac muscle for the rhythmic pumping action of the heart [249]. Di-
verse functions in the brain are attributed to a direct cell–cell communi-
cation proceeding via GJs, e.g. the formation of electrical synapses
between neurons [250] or a glial syncytium to support neuronal activity
[251]. Connexins, in the form of GJs or HCs, even contribute to blood–
brain barrier (BBB) functioning [55,252].
Currently, most evidence for intercellular Ca2+ signaling comes
from the brain where the communication of Ca2+ signals typically
emerges in glial networks, as well as neuronal and vascular cells
[50,253,254]. A number of neuro-pathological insults are associated
with intercellular Ca2+ waves and unwarranted cell death. In ischemic
stroke, acute cell death within the ischemic core predominantly pro-
ceeds via necrosis whilst the penumbral region is characterized by
autophagy, apoptosis and necrosis. Cell death in the penumbra may
occur over a period of days [255,256]. Cx channels have been proposed
to contribute to the gradual expansion of cell death from the core region
to the ischemic penumbral region during brain ischemia-related injury
[4,163,257]. Neurons are extremely prone to ischemia-induced damage
and gap junctional coupling between neurons has been shown to exac-
erbate neuronal death [258,259]. In addition, intercellular Ca2+ wave
propagation has been recently observed in vivo in networks of astro-
cytes, which are highly coupled via Cx43 GJs, in response to focal ische-
mia. The proposed Ca2+ changes contribute to neuronal damage
through the Ca2+-dependent release of glutamate. Loading of the astro-
cytes with the intracellular Ca2+ chelator BAPTA-AM reduced the in-
farct volume [260]. Glutamate receptor-mediated elevation in [Ca2+]i
due to inﬂux of extracellular Ca2+ and Ca2+ release from intracellular
stores, is considered to be one of themost important pathophysiological
processes leading to ischemic neuronal death [255,256]. Disturbances
in the ER Ca2+ handling may well account for ischemic cell damage
but the direct contribution of IP3/Ca2+ signaling remains obscure
[261]. Based on 45Ca2+ assays, Nagata et al. [262,263] reported that
IP3 binding activity is still preserved in the gerbil brain 30 min after
the induction of ischemia, whereas it is reduced 2 h and 6 h later in
the CA1 region of the hippocampus. The latter is the consequence of
an increased degradation of the IP3R1 and is proposed to be a secondary
phenomenon as a result of cellular damage. In a later study, Beresewicz
and colleagues [139] demonstrated that CytC interacts in vivowith the
IP3R1 and RyR2 in the gerbil hippocampus after ischemia/reperfusion.
Whether the functional consequences are similar to those observed in
in vitro settings, i.e. an ampliﬁcation of ER Ca2+ release, remains
unclear. Both the IP3R and the RyR have been shown to be involved in
ER Ca2+ release and neuronal cell death in cultured hippocampal neu-
rons in response to glycolysis inhibition [264].
The above-mentioned observations might be relevant to under-
stand the mechanisms involved in neuronal damage in ischemia as
well as in other neurodegenerative diseases which are associated
with a decrease in brain glucose utilization such as Alzheimer disease.
Intercellular Ca2+ wave signaling has also been implicated in the
pathogenesis of Alzheimer disease. More speciﬁcally, the presence
of amyloid β-peptide, a self-aggregating protein that damages neu-
rons, resulted in an increase of the amplitude and velocity of evoked
GJ- and ATP-mediated Ca2+ waves in astrocyte cultures [265]. Further-
more, spontaneously arising intercellular Ca2+ waves were noted in
vivo near amyloid-β plaques in astrocytes of Alzheimer mice using
two-photon microscopy [266]. Most neurodegenerative diseases are
characterized by the aggregation ofmisfolded proteinswhich promotes
cell death via ER stress. The synthesis of amyloid-β peptide is controlled
by presenilins (PS) that reside in the ER. Many PS mutations that areinvolved in familial Alzheimer disease enhance the gating of the IP3R
through an interaction of these proteins with the receptor, resulting in
increased ER Ca2+ release. The subsequent exaggerated Ca2+ signaling
gives rise to enhanced generation of ROS which signiﬁcantly contrib-
utes to the pathogenesis of this disease [267,268]. It is important to
note that mitochondrial dysfunction, and subsequent ROS generation,
represents an early event in many neurodegenerative diseases, includ-
ing Alzheimer, Parkinson, Huntington disease and amyotrophic lateral
sclerosis [269].
Apart from exacerbating cell death, propagating Ca2+ signals may
also contribute to neuro-inﬂammation, which is a hallmark in the cas-
cade of different neurodegenerative diseases. It has beneﬁcial as well
as unfavorable effects on the central nervous system [270]. A recent
study, carried out on zebraﬁsh larval brain, revealed that laser
light-induced neuronal injury initiates an intercellular Ca2+ wave
that travels throughout the brain and attracts microglia after which
they start to migrate towards the site of injury. The wave appeared
to be initiated by glutamate and is subsequently propagated across
the brain [271]. We recently demonstrated that endothelial cells ex-
posed to low extracellular Ca2+ display intercellular Ca2+ waves
which are associated with increased BBB permeability. We concluded
from this work that Cxs may form an interesting target to limit BBB
alterations under low extracellular Ca2+ conditions which can occur
in epilepsy, stroke and brain trauma [46].
While the role of RyR channels as a pathway for Ca2+ release from
the sarcoplasmic reticulum in heart cells has received considerable inter-
est, the speciﬁc function of IP3Rs in cardiac signaling has remained enig-
matic for a long time [248,272,273]. However, since the ﬁnding that
several cardiac diseases, including heart failure and hypertrophy, can
be linked to a disturbance in IP3/Ca2+ signaling, attention to this signal-
ing cascade has increased over the past decade. Firstly, intracellular Ca2+
increases are fundamental for the contraction of the heart muscle [274].
Several cardiac hormones (e.g. endothelin-1 and norepinephrine) that
generate IP3 are elevated during heart disease [275]. Increases in IP3
have been linked to the development of arrhythmias and a direct stimu-
lation of ventricular myocytes with an IP3 cell-permeable analogue
resulted in an enhanced contraction [276,277]. Although IP3Rs are
expressed at a lower level compared to RyRs, they are suggested to coop-
erate with RyRs to trigger sufﬁcient cytoplasmic Ca2+ release to evoke
cardiomyocyte contraction [278]. However, recent evidence obtained
from caged IP3 ﬂash photolysis experiments in the intact mouse heart
and in isolated ventricular myocytes demonstrates that IICR is not criti-
cally involved in intracellular Ca2+ dynamics associated with the action
potential and thus does not regulate excitation–contraction coupling
[279]. Secondly, the IP3/Ca2+ signaling cascade is suggested to play a
role in cardiomyocyte apoptosis, a process involved in heart failure
[280,281]. Davidson et al. recently demonstrated that slow Ca2+
waves, extending up to several hundreds of micrometers with a velocity
of 3.3 μm/s, synergize with oxidative stress to evoke PTP opening and
subsequently apoptosis in intact mice hearts during hypoxia and
reoxygenation [229]. Another recent paper provides evidence that IP3
and its receptor inhibit autophagy in cardiomyocytes. They suggest
that IP3R activation may contribute to cardiac pathology since a modest
increase in autophagy appears to be protective in certain diseased
heart conditions [282,283]. Thirdly, Ca2+ increases can also activate
genes that promote cardiac muscle hypertrophy. IP3-mediated Ca2+ sig-
nals have been observed in the nuclear region of cardiomyocytes
[284–286]. Thus, myocytes may be able to distinguish between global
Ca2+ signals involved in excitation–contraction and local nuclear IICR
that is linked to gene transcription [287]. It is important to note that
paracrine cell-to-cell propagating [Ca2+]i changes, evoked by mechani-
cal stimulation of HeLa cultures, appear to be initiated preferentially at
perinuclear ER sites whereas Ca2+ signals that are propagated by GJs
are generated almost at the site of the junctional channel [42].
Several reports have established a link between a dysfunctional
IP3/Ca2+ signaling system and disease pathogenesis. It is realistic to
1781E. Decrock et al. / Biochimica et Biophysica Acta 1833 (2013) 1772–1786assume that intercellular Ca2+ wave propagation, e.g. via diffusion of
IP3 through GJs, can be involved in the disease progression by
expanding the pathological insult. The above-mentioned examples
of brain and heart diseases thus suggest novel areas for further re-
search to explore the involvement of these waves, which might con-
tribute to novel therapeutic strategies.6. Conclusion
Direct cell–cell communication via GJs has been shown to contribute
to spread of cell death. We recently provided evidence for a crucial role
for the GJ-permeable molecule IP3 in driving bystander cells into apo-
ptosis [17]. Although IP3/Ca2+ signaling is known to stimulate different
processes that are critical for life, certain conditions may convert IP3
froma physiological to a killermessenger. The phenomenon of bystand-
er death has gained a great deal of attention as it opens up new avenues
to therapeutically limit exaggerated cell death in different pathological
conditions. However, gap junctional intercellular communication as
well as IP3/Ca2+ signaling are promiscuous signaling pathways used
by virtually all cells for a wide diversity of processes, and thus drugs
that target these pathways are expected to have major side effects.
Hence, identifying the terms (factors/molecules) that convert IP3 to a
toxic molecule, of which some possible candidates have been listed
in this review, may constitute an important strategy for the thera-
peutic prevention of unwarranted cell death in different pathologies
such as heart failure or neurodegenerative disease. Conversely, com-
bining intracellular IP3 loading with conventional anticancer therapies
(e.g. radiation which induces cell death proceeding via the intrinsic
mitochondria-related pathway) may promote intercellular cell death
spread between tumor cells and may thus provide new opportunities
to potentiate currently available anticancer strategies. In sum, although
it is an intriguing thought that such a powerfulmessage can hidewithin
one small molecule, the possibility of modulating cell death spread at
this level awaits the challenge of identifying additional factors involved.Acknowledgements
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